Evaluación de las reacciones agudas de la piel y sus factores de riesgo en pacientes con cáncer de mama sometidos a radioterapia by Pires, Ana Maria Teixeira et al.
844
RTOG CRITERIA TO EVALUATE ACUTE SKIN REACTION AND ITS RISK FACTORS IN
PATIENTS WITH BREAST CANCER SUBMITTED TO RADIOTHERAPY
Ana Maria Teixeira Pires1
Roberto Araujo Segreto2
Helena Regina Cômodo Segreto2
Pires AMT, Segreto RA, Segreto HRC. RTOG criteria to evaluate acute skin reaction and its risk factors in
patients with breast cancer submitted to radiotherapy. Rev Latino-am Enfermagem 2008 setembro-outubro;
16(5):844-9.
Purpose: Evaluate and classify skin reactions through the Radiation Therapy Oncology Group (RTOG) criteria
and characterize factors that can intervene in these reactions. Method: Prospective study, with 86 women
submitted to adjuvant breast radiotherapy with a total dose of 5040cGy, in a 6 MeV Linear Accelerator. Personal
data were collected and breast size was measured (distance between field separation and breast height). The
treated skin area was evaluated weekly. Results: Breast height and treatment technique were significant
factors in the univariate analysis for the incidence of degree 3 skin reactions. However, only breast height was
a significant factor in the multivariate analysis for the severity of skin reactions. The chances of occurring
degree 3 reactions increase 2.61 times for each increase in height unit (cm). These findings allow nurses to
plan more adequate and individualized procedures for each patient and contribute to the optimization of treatment.
DESCRIPTORS: radiotherapy; oncologic nursing; radiodermatitis; breast neoplasms
EVALUACIÓN DE LAS REACCIONES AGUDAS DE LA PIEL Y SUS FACTORES DE RIESGO EN
PACIENTES CON CÁNCER DE MAMA SOMETIDOS A RADIOTERAPIA
El objetivo fue evaluar y clasificar las reacciones de la piel según los criterios del Radiation Therapy Oncology
Group (RTOG) y caracterizar factores que puedan interferir en esas reacciones. Metodología: Estudio prospectivo,
con 86 mujeres sometidas a la radioterapia en la mama, dosis total de 5040cGy, con Acelerador Lineal de 6
MeV. Fueron recolectados datos personales y medido el tamaño de la mama (distancia entre la separación de
los campos y la altura de la mama). La evaluación de la piel del área de tratamiento fue realizada semanalmente.
Resultados: La altura de la mama y la técnica de tratamiento fueron significativos en el análisis univariado,
para incidencia de reacción de piel grado 3. Sin embargo, solamente la altura de la mama fue el factor
significativo en el análisis multivariado para la gravedad de la reacción de la piel. La probabilidad de ocurrir
una reacción grado 3 aumenta 2,61 veces por cada aumento de 1 unidad de altura en cm. Lo encontrado le
permite al enfermero planificar conductas más adecuadas e individualizadas para cada paciente y contribuir
para optimizar el tratamiento.
DESCRIPTORES: radioterapia; enfermería oncológica; radiodermatitis; neoplasias de la mama
AVALIAÇÃO DAS REAÇÕES AGUDAS DA PELE E SEUS FATORES DE RISCO EM PACIENTES
COM CÂNCER DE MAMA SUBMETIDAS À RADIOTERAPIA
O objetivo deste estudo foi avaliar e classificar as reações de pele, segundo os critérios do Radiation Therapy
Oncology Group (RTOG) e caracterizar fatores que possam interferir nessas reações. A metodologia usada foi
o estudo prospectivo, com 86 mulheres submetidas à radioterapia na mama, dose total de 5040cGy, com
Acelerador Linear de 6 MeV. Coletou-se dados pessoais e foi medido o tamanho da mama (distância entre a
separação dos campos e altura da mama). A avaliação da pele na área de tratamento foi realizada
semanalmente. Concluiu-se que a  altura da mama e a técnica de tratamento foram significantes na análise
univariada, para incidência de reação de pele grau 3. Porém, apenas a altura da mama foi fator significante na
análise multivariada para a gravidade da reação de pele. A chance de ocorrer reação grau 3 aumenta 2,61
vezes a cada aumento de 1 unidade de altura em cm. Esses achados permitem ao enfermeiro programar
condutas mais adequadas e individualizadas a cada paciente e contribuir para a otimização do tratamento.
DESCRITORES: radioterapia; enfermagem oncológica; radiodermatite; neoplasias da mama
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INTRODUCTION
Radiotherapy has been used as adjuvant
therapy in patients with breast cancer submitted to
conservative surgeries in initial stages. It aims to
diminish loco-regional recurrence and favor survival(1-2).
Skin reaction is one of the frequent adverse
reactions that occur in patients submitted to breast
cancer radiotherapy. Acute radiodermatitis begins
around the second/third week of treatment, due to
destruction of cells in the epidermal basal layer (loss
of permeability) with exposure of the dermis
(inflammatory process), and is manifested as
erythema, which can either progress to exudative
dermatitis or not(3-4).
In 1982, the Radiation Therapy Oncology
Group (RTOG) developed the Radiation Morbidity
Scoring Criteria to classify radiotherapy effects. It
identifies degree 0 (no reaction), 1 (faint erythema,
dry desquamation, epilation, diminished sweating), 2
(moderate, brisk erythema, exudative dermatitis in
plaques and moderate edema), 3 (exudative
dermatitis, besides cutaneous folds and intense
edema) and 4 (ulceration, hemorrhage, necrosis).
RTOG score has been widely employed for more than
25 years and is accepted and acknowledged by
medical and nursing communities(5).
The severity of skin reactions is attributed to
factors related to radiation, such as total dosage,
fractioning scheme, radiation energy (type of
equipment), volume of irradiated tissue and radio-
sensitivity of the tissue involved. It is believed that
patient-related factors, such as age, smoking,
coexistent chronic diseases and concomitant
antineoplastic treatment can interfere in skin reactions
due to the altered healing process(3).
It has been observed that breast size is an
important factor for stronger skin reactions. Large
breasts receive larger irradiation doses on the skin
to assure adequate dosage in deeper structures and
tissues(6). Thus, a significant part of the skin and breast
fold is exposed to radiation, increasing the irradiated
volume(6). However, there is no mathematical
parameter in literature that indicates how much breast
size increases chances of more severe acute skin
reactions.
Accurate knowledge on factors inherent to
patients, related to the disease and to the treatment
and their importance for the severity of skin reactions,
can certainly contribute to orientation and
individualized care, implementation of nursing care
and optimization of treatment. Recording this
information contributes to evaluate the patient at any
moment, to follow-up the treatment in a more
complex way and offer quality care(7).
Therefore, this study aimed to evaluate and
classify skin reactions according to the RTOG criteria
and characterize potential factors related to the
treatment and those inherent to patients that can
interfere in the reactions of women with breast cancer
submitted to radiotherapy.
Because of the above, observation and
classification of skin reactions caused by
radiotherapy, verification of factors related to the
treatment or intrinsic to each patient, which can
aggravate reactions, are relevant for orientations to
these patients, so that they can take adequate
measures to minimize and/or treat them, optimizing
the treatment.
CASUISTIC AND METHOD
This prospective study involved 86 women
with breast cancer diagnosis, who were submitted to
surgery (stages I, IIa and IIb) and adjuvant
radiotherapy in the Radiotherapy Centers at the
Federal University of São Paulo (UNIFESP) and the
Hospital Alemão Oswaldo Cruz (HAOC). The Research
Ethics Committees from both institutions approved
the study and all patients signed the free and informed
consent term. Data were collected according to the
evaluation instrument, with questions on histological
type, age, coexistent diseases (diabetes,
hypertension), previous or concomitant antineoplastic
treatment (scheme and date), smoking and family
cancer history. Women older than 18 year, who were
submitted to quadrantectomy or mastectomy with
reconstruction, were included in the study.
Radiotherapy was performed on the breast region,
tangential and parallel opposed fields, with a total dose
of 5040cGy (180cGy dose/day), with 6 MeV linear
accelerator. Two treatment techniques were used:
Source to skin distance (SSD) and isocenter. The breast
size was obtained from the contour drawing. The
distance between the field separation and the breast
height was measured (Figure 1).
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Figure 1 – Breast distance measure (d) and height
(h)(8)
All topical products prescribed by the
physicians were also recorded, though, due to their
variety, they were only considered as adjunct factors
in the irradiation effect on the skin.
Two observers (physician and researcher)
evaluated the treated skin area every week during
the six weeks of treatment and reactions were
classified using the RTOG scale. Breasts were marked
in the following regions: superior exterior quadrant
(QSE), superior internal quadrant (QSI), inferior
external quadrant (QIE), inferior internal quadrant
(QII), central quadrant (QC) and inframammary
region (IM). Reaction in the IM region was considered
only when lesion was located specifically in this region,
which differentiates from alteration in the inferior
quadrants.
Degrees 1 and 2 were grouped for
stat ist ical  analysis because they cause mi ld
symptoms and require simple conducts, which do
not limit the continuity of treatment. Fisher’s test
was used to analyze categorical variables and the
numerical variable age in relation to skin reactions.
To evaluate numerical variables, breast distance
and height, in relation to skin reactions, box-plots,
Fisher’s test and Logistic Regression were used.
To jointly evaluate the parameter technique and
breast height in relation to skin reactions, box-plots
and Logistical Regression were used. All tests were
fixed at a 5% significance level.
 
RESULTS
Table 1 shows the quantity of patients with
degree 1, 2 and 3 skin reactions.
Table 1 – Incidence of different degrees of skin
reactions due to radiotherapy. São Paulo, 2007
snoitcaeR N %
2dna1seergeD 17 %6.28
3eergeD 51 %4.71
latoT 68 %001
Table 2 shows the statistical results of logistic
regression in relation to breast height.
Table 2 – Final model of logistic regression according
to breast height. São Paulo, 2007
ledoM tneiciffeoC tneiciffeoC rorre-dradnats
evitpircseD
)p(level
tneiciffeoC
laitnenopxe
thgieH 6859.0 2072.0 100.0< 16.2
tnatsnoC 1985.8- 0211.2 100.0< 00.0
Chances of occurring degree 3 reactions (RTOG)
increase 2.61 at each increased height unit (cm).
The parameter breast height showed
statistical significance for the occurrence of degree 3
reactions according to Figure 2.
Figure 2 – Breast height according to the type of skin
reaction (d1/d2 e d3). São Paulo, 2007
Figure 3 shows the multivariate analysis to
verify the relevance of treatment technique and breast
height for skin reactions.
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Figure 3 – Height and treatment technique in relation
to the type of skin reaction. São Paulo, 2007
DISCUSSION
Breast skin reaction during radiotherapy,
though reversible in the majority of cases and less
frequent than in the past, is the most common side
effect in these patients and can affect the therapeutic
program and worsen quality of life. It occurs in several
phases of the treatment, initiates with mild intensity
and can develop to an intense degree, hindering the
continuity of applications. This variety of intensities
depends on factors related to radiation and individuals.
Thus, in this study, these parameters were
characterized in the study population and skin
reactions were correlated.
Antecedent cancer history is an expected
factor. Sixty-five percent of cancer incidence is
observed in our patients’ families, while an incidence
of up to 82.5%(3) is found in literature. It was not
possible to show significance, probably due to the
sample number.
Regarding the different levels of skin reactions,
the results reveal low incidence of degree 3 reactions
(17.4%) in comparison to degrees 1 and 2 (82,6%)
(Table 1). These data are comparable to those found
in literature, in which studies show evolution to degree
3 from 10 to 15% and from 7 to 20%(9). When the
breast region and the degree of skin reaction are
evaluated, 100% of degree 3 reactions were in the
inframammary region. Such results are found in
several studies, which show the predominance of
degree 3 reactions in this region because of the
constant friction and higher humidity in this area(3,10).
With regard to smoking, this factor did not
show statistical significance, probably due to the low
incidence of smokers in this population. The results
showed only 11.6% of smokers (10 patients), while
only one patient presented degree 3 reactions. There
is controversy in the literature regarding this issue
and, according to some authors, smoking does not
increase the risks for skin reactions(1). Anoxia
chronically caused by the smaller index of
oxyhemoglobin could even diminish the chances of
causing skin reaction because oxygen functions as a
radiosensitizer and its absence on skin would provide
resistance to the reaction(1). However, considering
radiobiological aspects, oxygen does not sensitize
tissues with physiological levels of oxygen but those
with low levels. Nevertheless, the reaction could be
worsened because of the nicotine and carbon
monoxide(11) action, which can hamper the healing
process. Thus, further research is needed on the
mechanisms of lesion caused by the association of
radiation and smoking and its importance as a risk
factor for skin reactions and healing process.
Regarding diabetes, only 8.1% of patients in
this study presented the disease. The small sample
size possibly did not permit statistical significance for
this parameter. However, no other study has showed
diabetes as a predisposing factor for the incidence of
more intense skin reactions. Because it is a systemic
pathology that interferes in healing phases, however,
it can delay healing and expose patients to higher
risks of infection(6).
In terms of hypertension, only 24.4% of
patients in this study were hypertensive and no
statistical significance was obtained with relation to
the severity of skin reaction. Hypertension is not
considered a predictive factor of skin reactions, though
it is a disease frequently associated to other co-
morbidities.
The average age of patients who had degree
3 reactions was higher. Differences were observed
between the average age of patients with degree 1
or 2 (58.31) and degree 3 reactions (64.47), but they
permitted borderline significance, probably due to the
size of the sample (p = 0.062), though it suggests a
tendency of degree 3 reactions in older women.
Literature shows that radiotherapy is well tolerated in
old patients and it is not the only contraindication for
the treatment(3). Yet, some authors suggest that,
because old people present smaller mitosis indices,
they would be less sensitive to radiation, which destroy
cells mainly in the mitosis phase and, consequently,
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would cause weaker skin reactions(3). However, the
elderly also present diminished production of collagen
and fibroblasts which, when associated to co-
morbidities (most frequent in older women), can harm
the healing process(3).
The researchers have observed in their daily
practice that age per se is no reason for concern.
Nevertheless, when age is associated to co-
morbidities, patients deserve a care program focused
not only on skin reactions, but also on encouragement
to self care and maintenance of health in other levels,
like the emotional and physical, among others.
Regarding treatment characteristics, it was
observed in this study that previous or concomitant
chemotherapy with radiotherapy was not a significant
factor for the severity of skin reactions, probably also
because of the small number of patients in these
situations. Different protocols and drugs were used
for the treatment. Literature does not show significant
interference of pre-radiotherapy chemotherapy in skin
reaction, but explains that young patients have a high
cellular turn-over, which increases susceptibility to
adverse reactions in the site(12). However, studies have
shown that chemotherapy concomitant with
radiotherapy significantly increases skin reactions in
these patients. Studies have also shown that
antracyclic drugs cause more adverse reactions than
the association of Cyclophosphamide, Methotrexate
and 5-Fluorouracil (CMF), though both can interfere
in the intensity and severity of skin reactions(2).
No statistically significant difference was found
in this study regarding the use of concomitant
hormonotherapy. Again, this result might be due to
the small number of patients with this characteristic.
The influence of tamoxifen on the incidence of
pulmonary fibrosis has been showed, but its effect on
skin has not been reported(10).
Reconstructive surgeries were performed in
11 patients (12.7%). The small sample size did not
permit verifying statistical significance in this case
either, but no patients developed degree 3 reactions
in this study. There is controversy in the literature
regarding radiotherapy after breast reconstruction
surgery, though the great concern is related to the
late effects of radiotherapy and not to skin reactions
during or right after the treatment(13). In relation to
data obtained in this study, possibly because
reconstructed breasts are smaller and not flab, they
do not favor humidity, friction and higher dosage
distributed on the skin, which would prevent
inframammary reactions.
Regarding topical therapy, 65.1% (N=56) of
patients used creams prescribed by radiotherapists
and there was a great variety of products. There is
controversy on their goal, regarding the prevention
of skin reactions, relief of symptoms or treatment
with the several products studied(3-4,6,11-14).
Corticosteroids and non-steroidal anti-inflammatory
drugs are frequently used for moderate to intense
reactions. However, they do not diminish inflammatory
response, delay all phases of the healing process and
increase the risk of local infection. Thus, they are
indicated for a limited time period(3).
Several studies consider breast size of great
importance because the volume irradiated is a factor
related to radiation and interferes in the incidence
and severity of side effects. There are several models
of breast measure to relate with skin reaction. The
bra size, maximum breast diameter(10) and volume in
centimeters3 were considered(14). The breast curve
drawing obtained in the planning for dosage calculation
was used in this study as previously reported. This
measure is considered reliable and easy to obtain
and reproduce. The measures were statistically
analyzed regarding their influence on skin reaction.
Breast distance was not a statistically
significant factor in the data analysis. The researchers
believe that this result occurred because breast
distance does not necessarily represent larger breasts.
In relation to the breast height, this parameter showed
statistical significance for the occurrence of degree 3
reactions (Figure 2). Patients with degree 3 reactions
presented a higher average breast height than patients
with degree 1 and 2 reactions (8.15 cm and 6.53cm
respectively). Larger breast volumes require that
larger doses be applied on skin to reach the desired
dosage in tissue and deeper structures. In addition,
adipose tissue has little vascularization and can delay
any healing process(6). These results corroborate with
those found in literature that show a proportionally
more intense skin reaction in medium and large
breasts(15). Data in the present study also show that
the chance of degree 3 reactions increases 2.61 times
at each height unit (cm) (Table 2).
Regarding the treatment technique used,
statistical difference was found in univariate analysis
between the isocenter and SSD techniques, showing
that the isocenter technique would increase the chance
of degree 3 skin reactions. Nevertheless, no study
was found comparing these two techniques or showing
higher incidence of skin reaction when the isocenter
technique is used.
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Therefore, multivariate analysis had to be
used to verify the importance of the treatment
technique and breast height for skin reactions. This
result definitely showed that the technique is not a
significant parameter for the occurrence of degree 3
skin reactions, when breast height is considered
(Figure 3).
When the results were jointly analyzed, they
revealed low incidence of degree 3 skin reactions in
the study population, and also that, when they
occurred, the inframammary region was the most
frequently affected area. They also show that breast
volume is the most important factor for the severity
of skin reactions in patients submitted to radiotherapy
in the breast region. Despite the low incidence of
severe skin reaction, care with the irradiated skin is
a relevant factor for radiotherapy in breast cancer.
There is little consensus between involved
professionals, and knowledge advancements
regarding the care of wounds have little impact on
patients with skin reactions caused by radiation(16-18).
In this context, the nurse is an important professional
in care for these patients. Such care has to be based
on each patient’s- individual data, breast physical
exam, and data collection on planning, with special
attention to breast height. These procedures allow
for better evaluation of the probability of undesirable
effects of radiotherapy and, then, adequate planning
and individualized care with a view to an uninterrupted
treatment and, consequently, better clinical response.
These measures allow for optimization of radiotherapy
and nursing care delivered to these patients.
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